These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310 [TBL] [Abstract][Full Text] [Related]
9. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls. Kaur K; Mehta S; Vanik S; Trivedi P; Banerjee N; Dhar H; Datta S; Karanjai S Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3769-3783. PubMed ID: 35267084 [TBL] [Abstract][Full Text] [Related]
10. An update on molecular diagnostics of squamous and salivary gland tumors of the head and neck. Hunt JL Arch Pathol Lab Med; 2011 May; 135(5):602-9. PubMed ID: 21526958 [TBL] [Abstract][Full Text] [Related]
11. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma. Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331 [TBL] [Abstract][Full Text] [Related]
12. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma. Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of fluorescence in situ hybridization testing on cytology cell blocks for the definitive classification of salivary gland neoplasms. Darras N; Mooney KL; Long SR J Am Soc Cytopathol; 2019; 8(3):157-164. PubMed ID: 31097292 [TBL] [Abstract][Full Text] [Related]
14. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup]. Fehr A; Stenman G; Bullerdiek J; Löning T Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654 [TBL] [Abstract][Full Text] [Related]
15. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct? Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284 [TBL] [Abstract][Full Text] [Related]
16. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences. Stenman G Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214 [TBL] [Abstract][Full Text] [Related]
17. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877 [TBL] [Abstract][Full Text] [Related]
18. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899 [TBL] [Abstract][Full Text] [Related]